PS
Puchalapalli Sankeerthi
About Puchalapalli Sankeerthi
Data last updated:
Puchalapalli Sankeerthi is a Director at Usk Therapeutics Private Limited (since 2021). The company operates in Pharma. Usk Therapeutics Private Limited reported revenue of ₹2.22 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Usk Therapeutics Private Limited U24290KA2021PTC152293 | Director | 27 Sep 2021 | 2021 | ₹2.22 Cr (FY 2025) | Active |
Board colleagues of Puchalapalli Sankeerthi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Katakam Ushasree | 09334920 | Usk Therapeutics Private Limited | Director |
| Ramakrishna Reddy Madakala | 05299506 | Usk Therapeutics Private Limited | Director |
| Sadu Kameswari | 09334918 | Usk Therapeutics Private Limited | Managing Director |
| Sobha Velamuru | 09334919 | Usk Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Puchalapalli Sankeerthi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Puchalapalli Sankeerthi
Puchalapalli Sankeerthi currently holds 1 directorship: Usk Therapeutics Private Limited (Director, since 27 Sep 2021, revenue ₹2.22 Cr (FY 2025)).
Puchalapalli Sankeerthi was first appointed on 27 Sep 2021 as Director at Usk Therapeutics Private Limited.
The current boards of Puchalapalli Sankeerthi's companies include Katakam Ushasree (Usk Therapeutics Private Limited), Ramakrishna Reddy Madakala (Usk Therapeutics Private Limited), Sadu Kameswari (Usk Therapeutics Private Limited), Sobha Velamuru (Usk Therapeutics Private Limited).